Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Capper

Showing results (271-280 of 350) with videos related to

Pageof 35
Sort By:
Neuro-Oncology|November 22, 2024
European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selectionFelix Sahm, Luca Bertero, Sebastian Brandner, et al.
Acta Neuropathologica|April 13, 2016
Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosisMartin Hasselblatt, Christian Thomas, Volker Hovestadt, et al.
Neuro-Oncology|August 17, 2022
BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytomaFlorian Selt, Romain Sigaud, Gintvile Valinciute, et al.
Neuro-Oncology|November 19, 2025
A framework for using DNA methylation-based modelling for the clinical management of cranial meningiomaAlexander P Landry, Justin Z Wang, Vikas Patil, et al.
The American Journal of Surgical Pathology|July 15, 2021
IDH2 R172 Mutations Across Poorly Differentiated Sinonasal Tract Malignancies: Forty Molecularly Homogenous and Histologically Variable Cases With Favorable OutcomeStefanie Glöss, Philipp Jurmeister, Anne Thieme, et al.
Nature Immunology|September 15, 2025
A spatial map of MAPK-activated immunosuppressive myeloid populations in pediatric low-grade gliomaAugusto Faria Andrade, Romain Sigaud, Evan Puligandla, et al.
British Journal of Cancer|February 16, 2024
AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implicationNanna Monjé, Mihnea P Dragomir, Bruno V Sinn, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 27, 2024
DNA Methylation Profiling of Salivary Gland Tumors Supports and Expands Conventional ClassificationPhilipp Jurmeister, Maximilian Leitheiser, Alexander Arnold, et al.
Acta Neuropathologica|October 8, 2013
AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistryFelix Sahm, Juliane Bissel, Christian Koelsche, et al.
Cancer Cell|May 16, 2018
Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized TrialAlan Mackay, Anna Burford, Valeria Molinari, et al.
Pageof 35

Showing results (271-280 of 350) with videos related to

Sort By:
Pageof 35
Neuro-Oncology|November 22, 2024
European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selectionFelix Sahm, Luca Bertero, Sebastian Brandner, et al.
Acta Neuropathologica|April 13, 2016
Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosisMartin Hasselblatt, Christian Thomas, Volker Hovestadt, et al.
Neuro-Oncology|August 17, 2022
BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytomaFlorian Selt, Romain Sigaud, Gintvile Valinciute, et al.
Neuro-Oncology|November 19, 2025
A framework for using DNA methylation-based modelling for the clinical management of cranial meningiomaAlexander P Landry, Justin Z Wang, Vikas Patil, et al.
The American Journal of Surgical Pathology|July 15, 2021
IDH2 R172 Mutations Across Poorly Differentiated Sinonasal Tract Malignancies: Forty Molecularly Homogenous and Histologically Variable Cases With Favorable OutcomeStefanie Glöss, Philipp Jurmeister, Anne Thieme, et al.
Nature Immunology|September 15, 2025
A spatial map of MAPK-activated immunosuppressive myeloid populations in pediatric low-grade gliomaAugusto Faria Andrade, Romain Sigaud, Evan Puligandla, et al.
British Journal of Cancer|February 16, 2024
AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implicationNanna Monjé, Mihnea P Dragomir, Bruno V Sinn, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 27, 2024
DNA Methylation Profiling of Salivary Gland Tumors Supports and Expands Conventional ClassificationPhilipp Jurmeister, Maximilian Leitheiser, Alexander Arnold, et al.
Acta Neuropathologica|October 8, 2013
AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistryFelix Sahm, Juliane Bissel, Christian Koelsche, et al.
Cancer Cell|May 16, 2018
Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized TrialAlan Mackay, Anna Burford, Valeria Molinari, et al.
Pageof 35